Today's News | Note: News feeds may no longer be available for the articles on this page.

Drug price controls may shorten lives -report 3:08 AM 12/16/2008
Reuters - USA
European-style price controls on prescription drugs in the US would result in modest cost savings and less innovation. ...

Elan, Biogen report new Tysabri brain disease case 10:20 AM 12/15/2008
CNNMoney.com - USA
Biogen Idec and Elan Corp report the fourth case this year of a deadly brain infection in a patient taking their multiple-sclerosis drug Tysabri. ...

Lundbeck moves to Phase III with alcoholism drug 5:08 AM 12/15/2008
Reuters - USA
Lundbeck will start Phase III clinical trials for its alcohol dependence drug nalmefene. It's hoped the drug will limit the patient's alcohol intake. ...

Novartis Touts MS Drug Study 4:48 AM 12/15/2008
Wall Street Journal - USA
Novartis AG said that development drug FTY720 for the treatment of multiple sclerosis was shown to work better than treatment from rival Biogen Idec. There were seven cases of skin cancer among patients that received the Novartis drug. ...

Synta gets $15m from Glaxo on cancer drug 6:36 AM 12/13/2008
Boston Globe - United States
Synta Pharmaceuticals Corp received $15 million from GlaxoSmithKline for the potential cancer treatment elesclomol. Synta is eligible for a total of $585 million in milestone payments for progress in clinicals or regulatory filings. ...

An EXELent Drug Deal 3:33 AM 12/13/2008
Motley Fool - USA
Exelixis guided to have at least $200 million in the bank at the end of 2008. It picked up $195 million in a deal with Bristol-Myers Squibb. ...

Study of Tumor Recurrence May Change Drug Guidelines 12:37 AM 12/13/2008P
New York Times - United States
A fast-growing form of breast cancer must be treated aggressively after surgery even when tumors are very small. This could alter treatment for 20% of women diagnosed with breast cancer. ...

Gilead Sciences Files Patent Infringement Lawsuit Against Teva ... 4:02 PM 12/12/2008
Welt Online - Germany
Gilead Sciences, Inc filed a lawsuit in US District Court against Teva Pharmaceuticals USA and Teva Pharmaceutical Industries for infringement of patents for emtricitabine. ...

Elan Faces Pressure from Holders 2:22 PM 12/12/2008
Wall Street Journal - USA
By JEANNE WHALEN Pressure is mounting on drug maker Elan Corp.'s chief executive and board as large shareholders voice dissatisfaction with the firm's ...

Schering-Plough hepatitis C drug approved for kids 12:38 PM 12/12/2008
The Associated Press
The US FDA has approved Schering-Plough's Rebetol with PEG-Intron, an advanced, genetically engineered version of the immune system protein interferon for hepatitis C in children. ...

US FDA questions Lilly, Amgen cancer drug trials 9:14 AM 12/12/2008
Reuters - USA
The US FDA is questioning whether proposed clinical trials are enough to show patients with the KRAS gene benefit more from ImClone's Erbitux and Amgen's Vectibix. ...

Bristol-Myers, Biotech Firm to Develop Cancer Drugs 6:31 AM 12/12/2008
Wall Street Journal - USA
Bristol-Myers Squibb joins forces with biotechnology company Exelixis Inc to develop two experimental cancer drugs. The pact has Bristol-Myers paying at least $240 million. ...

US FDA panel says two asthma drugs risky 4:41 AM 12/12/2008
Reuters - USA
GlaxoSmithKline's Serevent and Novartis' Foradil pose serious risks that outweigh their benefits. Glaxo's Advair and AstraZeneca's Symbicort are acceptable. ...

Glaxo, Novartis drug combo delays breast cancer 6:23 PM 12/11/2008
Reuters - USA
GlaxoSmithKline's Tykerb (lapatinib) combined with Novartis's Femara (letrozole) can delay the progression of breast cancer in some women. ...

FDA Puts Black Box Warning on Bowel-Cleansing Drugs 4:24 PM 12/11/2008
Washington Post - United States
The US FDA will now require a black-box warning on the oral sodium phosphate products Visicol and OsmoPrep to alert patients about the risk of acute phosphate nephropathy (severe kidney injury). ...

<- Day Earlier | Today's News